Summary

Digital Diagnostics Market Size
The global digital diagnostics market size was valued at $1.72 billion in 2024 and is projected to reach $5.12 billion by 2030, growing at a CAGR of 20.0% during the forecast period.

Digital Diagnostics Market Overview
Digital diagnostics refers to the use of digital technologies and tools to enhance the detection, diagnosis, and monitoring of diseases. This field leverages advancements in artificial intelligence, machine learning, data analytics, and digital imaging to improve the accuracy, efficiency, and accessibility of diagnostic processes. Digital diagnostics encompasses a wide range of applications, including telemedicine platforms for remote consultations, digital pathology for analyzing medical images, wearable devices that continuously monitor health parameters, and mobile health applications that facilitate self-diagnosis and tracking of symptoms. By integrating these technologies, digital diagnostics aims to provide faster and more accurate diagnostic information, support personalized treatment plans, and ultimately improve patient outcomes. This approach also enables better data management and sharing among healthcare providers, enhancing collaborative care and decision-making.

Digital Diagnostics Market Dynamics
• The digital diagnostics market is expected to witness significant growth in the future due to increasing prevalence of chronic diseases, advances in artificial intelligence and machine learning, and growing adoption of telemedicine and remote monitoring.
• Additionally, the rising demand for personalized medicine, technological advancements in digital imaging and data analytics, and expansion of telehealth services are the prominent factors driving the growth of the digital diagnostics market.
• However, the high cost of digital diagnostic tools and technologies, data privacy and security concerns, and limited digital infrastructure in developing regions are restraining the market growth.
• On the contrary, the integration with electronic health records (EHR) systems, development of cost-effective and portable diagnostic devices, and collaboration between tech companies and healthcare providers are creating opportunities for market growth.

By Application, the Oncology Segment is anticipated to Exhibit Significant Growth Rate in the Digital Diagnostics Market
The oncology segment is expected to grow at a high growth rate in the digital diagnostics market during the forecast period owing to the critical need for early and accurate cancer detection, which significantly impacts treatment outcomes and patient survival rates. Digital diagnostics leverage advanced technologies such as artificial intelligence, machine learning, and digital imaging to improve the precision and speed of cancer diagnosis, enabling the identification of malignancies at earlier stages. This is particularly important in oncology, where timely intervention can greatly enhance the effectiveness of treatments. Additionally, digital diagnostics facilitate personalized medicine by providing detailed molecular and genetic information about tumors, allowing for tailored treatment plans that target specific cancer types and mutations. The integration of these technologies into routine clinical practice also supports continuous monitoring and assessment of cancer progression and response to treatment, leading to more informed decision-making and better patient management.

By Geography, North America Constitutes Immense Share with the Digital Diagnostics Market
North America holds a prominent share of the digital diagnostics market during the forecast period due to the increasing prevalence of chronic diseases, the rising adoption of technologies for chronic disease management, substantial investments, frequent product launches, and strategic initiatives by major market players. The region faces a substantial burden of chronic diseases such as cancer, diabetes, and cardiovascular conditions, necessitating efficient and accurate diagnostic tools for early detection and management. Additionally, North America has a robust healthcare system with a high level of adoption for new technologies, making it a fertile ground for digital diagnostics. The increasing investments in healthcare IT and the growing trend towards personalized medicine further fuel the demand for digital diagnostic solutions. Moreover, the presence of major market players and continuous product innovation contribute to the market's growth. Regulatory support and favorable reimbursement policies also play a crucial role in enhancing the adoption of digital diagnostics.
• According to the American Cancer Society in 2022, approximately 236,740 new cases of lung cancer and 79,000 new cases of kidney cancer are expected to be diagnosed, with 13,920 deaths anticipated from kidney cancer. This high incidence of cancer is likely to drive the demand for digital diagnostic devices, thereby propelling market growth.

Key Target Audience:
• Healthcare Providers
• Diagnostic Laboratories
• Medical Device Manufacturers
• Pharmaceutical Companies
• Research Institutions

List of the Key Players Profiled in the Report Includes:
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• GE Healthcare
• Siemens Healthineers
• Medtronic plc
• Nano-X Imaging Ltd.
• Koninklijke Philips N.V.
• Digital Diagnostics Inc.
• Riverain Technologies
• VUNO, Inc.
• AliveCor, Inc.

Recent Developments:
• In June 2024, Roche announced that the Roche Digital Pathology Dx (VENTANA DP 200), its whole-slide imaging system, has obtained 510(k) clearance from the United States Food and Drug Administration (FDA). This system is designed to assist pathologists in reviewing and analyzing digital images of scanned pathology slides to aid in patient diagnosis.
• In June 2024, Thermo Fisher Scientific Inc has launched the Thermo Scientific KingFisher PlasmidPro Maxi Processor (PlasmidPro) in Waltham, Mass. This innovative system represents the industry's first fully automated maxi-scale plasmid DNA (pDNA) purification solution.

Market Segmentation:
The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Product:
• Hardware
• Software
• Services

Market by, End User:
• Clinical Laboratories
• Hospitals
• Other End Users

Market by, Application:
• Cardiology
• Neurology
• Oncology
• Pathology
• Radiology
• Other Applications

Market by, Geography:
The digital diagnostics market report also analyzes the major geographic regions and countries of the market. The regions and countries covered in the study include:
• North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis
• Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis
• South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis
• Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis

Scope of the Report:
The report “Global Digital Diagnostics Market: Industry Analysis, Opportunities and Forecast up to 2030” by Diligence Insights provides a detailed analysis of the present market and future outlook with market estimates and forecasts for all specified segments, encompassing both global and regional perspectives as outlined within the research framework. The study includes historical market data for the years 2022, 2023 and offers revenue estimations for 2024, and project forecasts spanning from 2025 to 2030. It places significant emphasis on the examination of market trends, key industry participants, supply chain developments, technological advancements, pivotal milestones, and prospective strategies. Comprehensive market assessments are carried out across major geographic regions, including North America, Europe, Asia Pacific, South America, and Middle East & Africa. As such, this report constitutes a valuable resource for current industry stakeholders, newcomers to the field, and potential investors.

The study offers an in-depth market analysis, drawing insights from industry experts across the value chain. A special focus has been made on 25 countries, including the United States, Canada, Mexico, the United Kingdom, Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, and South Africa, among others. The market data has been meticulously collected through extensive primary interviews and comprehensive secondary research. Market size determination is rooted in the revenue generated from sales across all the specified segments and sub-segments as defined within the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The report offers insights into the following aspects:
• Analysis of major market trends, factors driving, restraining, threatening, and providing opportunities for the market.
• Analysis of the market structure by identifying various segments and sub-segments of the market.
• Understand the revenue forecast of the market for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
• Analysis of opportunities by identification of high-growth segments/revenue pockets in the market.
• Understand major player profiles in the market and analyze their business strategies.
• Understand competitive developments such as joint ventures, alliances, mergers and acquisitions, and new product launches in the market.

ページTOPに戻る

Table of Contents

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations

2 Executive Summary

3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions

4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges

5 Porter's Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market

6 Global Digital Diagnostics Market by, Product
6.1 Overview
6.2 Hardware
6.3 Software
6.4 Services

7 Global Digital Diagnostics Market by, End User
7.1 Overview
7.2 Clinical Laboratories
7.3 Hospitals
7.4 Other End Users

8 Global Digital Diagnostics Market by, Application
8.1 Overview
8.2 Cardiology
8.3 Neurology
8.4 Oncology
8.5 Pathology
8.6 Radiology
8.7 Other Applications

9 Global Digital Diagnostics Market by, Geography
9.1 Overview
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 New Zealand
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 Qatar
9.6.4 Iran
9.6.5 South Africa
9.6.6 Rest of Middle East & Africa

10 Key Developments

11 Company Profiling
11.1 F. Hoffmann-La Roche Ltd
11.1.1 Business Overview
11.1.2 Product/Service Offering
11.1.3 Financial Overview
11.1.4 SWOT Analysis
11.1.5 Key Activities
11.2 Thermo Fisher Scientific Inc.
11.3 Laboratory Corporation of America Holdings
11.4 GE Healthcare
11.5 Siemens Healthineers
11.6 Medtronic plc
11.7 Nano-X Imaging Ltd.
11.8 Koninklijke Philips N.V.
11.9 Digital Diagnostics Inc.
11.10 Riverain Technologies
11.11 VUNO, Inc.
11.12 AliveCor, Inc.